| 000 | 01583 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515064054.0 | ||
| 264 | 0 | _c20070601 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1075-2617 | ||
| 024 | 7 |
_a10.1002/psc.849 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPakkala, Miikka | |
| 245 | 0 | 0 |
_aActivity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors. _h[electronic resource] |
| 260 |
_bJournal of peptide science : an official publication of the European Peptide Society _cMay 2007 |
||
| 300 |
_a348-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligopeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Structure, Quaternary |
| 650 | 0 | 4 |
_aSerine Proteinase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTissue Kallikreins _xantagonists & inhibitors |
| 700 | 1 | _aHekim, Can | |
| 700 | 1 | _aSoininen, Pasi | |
| 700 | 1 | _aLeinonen, Jari | |
| 700 | 1 | _aKoistinen, Hannu | |
| 700 | 1 | _aWeisell, Janne | |
| 700 | 1 | _aStenman, Ulf-Håkan | |
| 700 | 1 | _aVepsäläinen, Jouko | |
| 700 | 1 | _aNärvänen, Ale | |
| 773 | 0 |
_tJournal of peptide science : an official publication of the European Peptide Society _gvol. 13 _gno. 5 _gp. 348-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/psc.849 _zAvailable from publisher's website |
| 999 |
_c16986779 _d16986779 |
||